4 completed, 1 terminated, 1 withdrawn. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
Follow Restasis: new trials by email Literature Review of Restasis trials Research Report on Restasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax Cyclosporine, Loteprednol Etabonate, Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert - Dry Eye | Phase 4 | Completed | Thomas Chester, OD | 30 | 2020-10-01 | 2023-10-11 |
| A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® Loteprednol etabonate, Artificial Tears, Restasis - Dry Eye Disease | Phase 4 | Withdrawn | Edward Holland, MD | 2014-01-01 | 2015-03-18 | |
| Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease Restasis, Refresh Endura - Primary Sjogren Syndrome, Secondary Sjogren Syndrome | Phase 4 | Completed | Federal University of São Paulo | 100 | 2013-01-01 | 2020-09-22 |
| Topical Cyclosporine and Disease Progression Restasis, Endura - Disease Progression, Disease Severity | Phase 4 | Completed | Innovative Medical | 80 | 2007-12-01 | 2008-09-25 |
| The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye Cyclosporine A 0.05%, Arificial Tear - Dry Eye | Phase 4 | Terminated | Massachusetts Eye and Ear Infirmary | 8 | 2007-08-01 | 2017-03-28 |
| Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis Lotemax, Restasis - Dry Eye Disease, Keratoconjunctivitis Sicca | Phase 4 | Completed | Ophthalmic Consultants of Long Island | 5 | 2006-11-01 | 2011-07-21 |
Dry Eye Syndromes (5) · Disease Progression (1) · Graft vs Host Disease (1) · Keratoconjunctivitis Sicca (1)
Edward Holland, MD (1) · Federal University of São Paulo (1) · Innovative Medical (1) · Massachusetts Eye and Ear Infirmary (1) · Ophthalmic Consultants of Long Island (1) · Thomas Chester, OD (1)
United States (5) · Brazil (1)
Maria Howard (1) · Reza Dana, M.D. (1) · Rossen M Hazarbassanov, PhD (1) · Sanjay Rao (1)